Newsletter | August 20, 2026

Take Another Angle To The FDA Focus On Psychedelic Research

SPONSOR

PMWC 2027 Program Is Live

PMWC 2027: The program is live. Explore 15 focused programs spanning next-generation therapeutics, AI and computational medicine, precision diagnostics, and integrated precision medicine. Co-hosted by Stanford, UCSF, and Yale, PMWC features leaders including David Baker, Emmanuelle Charpentier, Andrew Ng, Fei-Fei Li, and Mary-Claire King, January 27-29, 2027, at the Santa Clara Convention Center.

REGULATORY COMPLIANCE

What The FDA's Latest Move On Psychedelics Means For Non-Hallucinogenic Drug Sponsors

Taking another angle to the FDA focus on psychedelic research, Enveric Biosciences CEO Joseph Tucker, Ph.D., explores what the FDA’s moves mean for non-hallucinogenic drug sponsors.

From Bench To Breakthrough: How Custom Kitting Fuels Precision Trials

Reduce trial variability and ensure protocol compliance with standardized custom kitting that transforms complex sample collection into a streamlined, strategic advantage for clinical success.

5 Ways To Get Ready For IRT Regulatory Inspections

Preparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.

FDA Approval Of Novel Agents For The Acute Treatment Of Migraine

Parallel trials, compressed timelines, thousands of patients. Discover the data oversight strategies that kept two programs on track to approval

Who Is Responsible When AI Helps Write The Consent Form?

AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.

The Growing Complexity Of Conducting Oncology Trials

As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.

Early Development And Innovation

Early-phase decisions are critical to the long-term success of your innovations. Learn about a multidisciplinary approach that can bolster your clinical evidence and accelerate proof of concept.

OUTSOURCING MODELS

5 Signs Your Clinical Trial Needs Outside Help

Could you use some outside help? The right outside partner can bring the expertise, capacity, and perspective needed to get studies back on track.

A Strategic Guide To FSP Models In Clinical Development

Ready to scale your clinical trials without sacrificing quality? Explore a practical framework for building flexible, high-capacity partnerships across the development lifecycle.

Distribution Automation System For Clinical Supply Chains

Automated storage and retrieval technology reduces mis-picks, speeds order processing, and keeps clinical trial materials moving on time as study demands shift.

Cardiovascular, Renal And Metabolic Clinical Development

CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.

Immune Challenge Models For Early Drug Development

Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.

Connect With Clinical Leader: